Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

BACKGROUND: Patients with both diabetes mellitus (DM) and chronic kidney disease (CKD) are a subpopulation characterized by ultrahigh ischemic and bleeding risk after percutaneous coronary intervention. There are limited data on the impact of ticagrelor monotherapy among these patients. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chao, Tomaniak, Mariusz, Takahashi, Kuniaki, Kawashima, Hideyuki, Wang, Rutao, Hara, Hironori, Ono, Masafumi, Montalescot, Gilles, Garg, Scot, Haude, Michael, Slagboom, Ton, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, van Geuns, Robert-Jan, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Angiolillo, Dominick J., Serruys, Patrick W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568378/
https://www.ncbi.nlm.nih.gov/pubmed/33066794
http://dx.doi.org/10.1186/s12933-020-01153-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568378/
https://www.ncbi.nlm.nih.gov/pubmed/33066794
http://dx.doi.org/10.1186/s12933-020-01153-x

Ejemplares similares